Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
2024 · Science · 91 citations
https://doi.org/10.1126/science.adk0775
H
Hey Min Lee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
347
Citations
8
h-index
7
i10-index
Hey Min Lee is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Research and Treatments & Genetic factors in colorectal cancer. The author has an h-index of 8, co-authored 48 publications.
ORCID: 0000-0001-7792-4226Papers by this author
worksChromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer
2021 · Gut · 78 citations
https://doi.org/10.1136/gutjnl-2020-322835
Data from Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human <i>BRAFV600E</i> mutant colorectal cancer.
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.6618070.v4
Supplementary Figure 1 from Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human <i>BRAFV600E</i> mutant colorectal cancer.
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27030835.v1
Supplementary Figure S7 from Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAF<sup>V600E</sup>-Mutated Colorectal Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27754894
Supplementary Figure S5 from Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAF<sup>V600E</sup>-Mutated Colorectal Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27754903
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat